- Report
- March 2024
- 295 Pages
Global
From €4027EUR$4,197USD£3,482GBP
- Report
- March 2024
- 181 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- January 2024
- 150 Pages
Global
From €4654EUR$4,850USD£4,024GBP
- Report
- March 2024
- 185 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- May 2024
- 188 Pages
Global
From €5373EUR$5,600USD£4,646GBP
- Report
- October 2023
- 200 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- May 2024
- 289 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- November 2023
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- November 2023
- 148 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- October 2023
- 172 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- November 2023
- 171 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- June 2023
- 111 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 175 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- September 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- August 2023
- 102 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1439EUR$1,500USD£1,245GBP
The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more